Case report assesses iodine-131-metaiodobenzylguanidine therapy's efficacy in pheochromocytoma, suggesting further evaluation is needed.
I-MIBG therapy appears promising, its efficacy requires further assessment due to the limited number of reported cases of MEN2A-associated metastatic pheochromocytoma.
No takes yet. Share an insight, caveat, or question.
Suda et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: